Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Immunotherapy Toxicity”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 8 of 0 results

Not applicableUnknownNCT06287320
What this trial is testing

The Predictive Biomarkers in Patients With Locally Advanced Non-small Cell Lung Cancer

Who this might be right for
Locally Advanced Non-small Cell Lung Cancer
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 200
Testing effectiveness (Phase 2)UnknownNCT01883518
What this trial is testing

Autologous Dendritic Cell Vaccine in Patients With Soft Tissue Sarcoma

Who this might be right for
SarcomaNeoplasms, Connective and Soft Tissue
N.N. Petrov National Medical Research Center of Oncology 48
Not applicableLooking for participantsNCT05832606
What this trial is testing

Food Intervention to Reduce Immunotherapy ToXicity

Who this might be right for
Immune-related Adverse EventDietary Habits
Universitair Ziekenhuis Brussel 60
Early research (Phase 1)Study completedNCT05216835
What this trial is testing

Safety and Preliminary Efficacy Assessment of AZD7789 in Patients With Relapsed or Refractory Classical Hodgkin Lymphoma

Who this might be right for
Relapsed or Refractory Classical Hodgkin Lymphoma
AstraZeneca 45
Not applicableUnknownNCT04107168
What this trial is testing

Microbiome Immunotherapy Toxicity and Response Evaluation

Who this might be right for
MelanomaRenal CancerLung Cancer
CCTU- Cancer Theme 1,800
Not applicableNot Yet RecruitingNCT06900296
What this trial is testing

ImmuNe ParameTERs to Predict Immunotherapy REsponse and Toxicity (INTERPRET)

Who this might be right for
Cancer
Indiana University 100
Testing effectiveness (Phase 2)Study completedNCT01368107
What this trial is testing

Study Evaluating Impact of IL-7 on CD4 Lymphopenia, Risks of Severe Haematological Toxicity and Tumor Progression in Metastatic Breast Cancer Patients

Who this might be right for
Metastatic Breast Cancer
Centre Leon Berard 24
Very early researchLooking for participantsNCT03719105
What this trial is testing

Chemoimmunotherapy and Allogeneic Stem Cell Transplant for NK T-cell Leukemia/Lymphoma

Who this might be right for
NK-Cell LymphomaNK-Cell LeukemiaPeripheral T Cell Lymphoma
New York Medical College 40